Comparison of CA 125 assays with abdominopelvic computed tomography and transvaginal ultrasound in monitoring of ovarian cancer

This publication has 16 references indexed in Scilit:

• What Is a Normal CA125 Level?
  Gynecologic Oncology, 1994
• Is there a role for CT scanning to monitor therapy of optimally debulked patients with advanced ovarian epithelial cancer?
  International Journal of Gynecologic Cancer, 1994
• CT and MR Accuracy in the Detection of Tumor Recurrence in Patients Treated for Ovarian Cancer
  Journal of Computer Assisted Tomography, 1993
• Long-term follow-up of ovarian cancer with monthly determinations of serum CA 125
  Gynecologic Oncology, 1992
• Monitoring patients with ovarian carcinoma: the relationship of serum CA125 levels to CT scanning
  International Journal of Gynecologic Cancer, 1991
• Ovarian cancer: The prognostic value of the serum half-life of CA125 during induction chemotherapy
  Gynecologic Oncology, 1988
• Predictive value of serial CA 125 antigen levels in ovarian cancer evaluated by second-look laparotomy
  European Journal of Cancer and Clinical Oncology, 1987
• Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second‐look operations and their role in the detection of tumour recurrence
  BJOG: An International Journal of Obstetrics and Gynaecology, 1987
• CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer Patients
  Obstetrics & Gynecology, 1986
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983